A detailed history of Gw Henssler & Associates LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Gw Henssler & Associates LTD holds 711 shares of UTHR stock, worth $249,681. This represents 0.02% of its overall portfolio holdings.

Number of Shares
711
Previous 711 -0.0%
Holding current value
$249,681
Previous $254,000 1.57%
% of portfolio
0.02%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$311.04 - $363.55 $221,149 - $258,484
711 New
711 $254,000
Q1 2023

Apr 26, 2023

BUY
$212.99 - $276.17 $2,555 - $3,314
12 Added 0.91%
1,324 $296,000
Q3 2022

Nov 04, 2022

SELL
$203.3 - $244.17 $37,000 - $44,438
-182 Reduced 12.18%
1,312 $275,000
Q2 2022

Aug 04, 2022

SELL
$174.81 - $241.14 $319,203 - $440,321
-1,826 Reduced 55.0%
1,494 $352,000
Q1 2022

May 09, 2022

BUY
$166.16 - $213.96 $830 - $1,069
5 Added 0.15%
3,320 $596,000
Q4 2021

Jan 28, 2022

BUY
$184.32 - $216.08 $611,020 - $716,305
3,315 New
3,315 $716,000
Q3 2021

Nov 02, 2021

SELL
$179.86 - $214.88 $549,472 - $656,458
-3,055 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$170.47 - $211.93 $12,444 - $15,470
73 Added 2.45%
3,055 $548,000
Q4 2020

Feb 02, 2021

BUY
$101.87 - $151.79 $1,629 - $2,428
16 Added 0.54%
2,982 $453,000
Q3 2020

Oct 22, 2020

BUY
$99.9 - $121.13 $10,489 - $12,718
105 Added 3.67%
2,966 $300,000
Q2 2020

Jul 21, 2020

SELL
$92.74 - $125.82 $137,997 - $187,220
-1,488 Reduced 34.21%
2,861 $346,000
Q1 2020

Apr 27, 2020

SELL
$79.39 - $115.35 $20,244 - $29,414
-255 Reduced 5.54%
4,349 $412,000
Q4 2019

Feb 24, 2020

BUY
$78.31 - $95.34 $62,961 - $76,653
804 Added 21.16%
4,604 $406,000
Q3 2019

Nov 18, 2019

SELL
$74.85 - $85.99 $44,910 - $51,594
-600 Reduced 13.64%
3,800 $303,000
Q2 2019

Aug 05, 2019

BUY
$76.06 - $120.81 $70,583 - $112,111
928 Added 26.73%
4,400 $343,000
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $372,024 - $440,388
3,472 New
3,472 $408,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Gw Henssler & Associates LTD Portfolio

Follow Gw Henssler & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.